Literature DB >> 22665572

Management of a large retroperitoneal primitive neuroectodermal tumour: 'a multimodal approach'.

Shailesh Sable1, Vidhyachandra Gandhi, Aabha Nagral, Sanjay Nagral.   

Abstract

Retroperitoneal primitive neuroectodermal tumour (PNET) is a rare disease having poor prognosis. Treatment mainly consists of en block resection of the tumour to achieve RO resection, however multimodal approach has also been used with improved survival. The authors report a 40-year-old male with large retroperitoneal PNET adherent to aorta and compressing the inferior vena cava. He was subjected to P6 protocol chemotherapy (cyclophosphamide, adriamycin, vincristine, ifosfamide and etoposide) in view of borderline operability. Postchemotherapy contrast enhanced CT revealed significant reduction in size of the lesion. He underwent complete resection of the tumour followed by concurrent chemoradiation. He remains asymptomatic on follow-up over a period of 2 years.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22665572      PMCID: PMC3291040          DOI: 10.1136/bcr.12.2011.5459

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Laparoscopic removal of extraosseous Ewing's sarcoma of the kidney in a pediatric patient.

Authors:  Elise Perer; Allan M Shanberg; Garrett Matsunaga; Jerry Z Finklestein
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2006-02       Impact factor: 1.878

Review 2.  Imaging features of peripheral primitive neuroectodermal tumours.

Authors:  S Hari; T P Jain; S Thulkar; S Bakhshi
Journal:  Br J Radiol       Date:  2008-09-01       Impact factor: 3.039

3.  Primitive neuroectodermal peripheral tumour of the retroperitoneum.

Authors:  C Alvarez-Laso; E Azcano; J González; I González-Pinto
Journal:  Clin Transl Oncol       Date:  2008-06       Impact factor: 3.405

4.  Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients.

Authors:  H Jürgens; V Bier; D Harms; J Beck; W Brandeis; G Etspüler; H Gadner; D Schmidt; J Treuner; K Winkler
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

5.  Results of multimodal treatment for desmoplastic small round cell tumors.

Authors:  Dave R Lal; Wendy T Su; Suzanne L Wolden; Kenneth C Loh; Shakeel Modak; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2005-01       Impact factor: 2.545

6.  Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.

Authors:  E H Baldini; G D Demetri; C D Fletcher; J Foran; K C Marcus; S Singer
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

7.  MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.

Authors:  I M Ambros; P F Ambros; S Strehl; H Kovar; H Gadner; M Salzer-Kuntschik
Journal:  Cancer       Date:  1991-04-01       Impact factor: 6.860

8.  Radiologic findings of peripheral primitive neuroectodermal tumor arising in the retroperitoneum.

Authors:  Mi Sung Kim; Bohyun Kim; Chan Sup Park; Soon Young Song; Eun Ja Lee; Noh Hyuck Park; Hye-Seong Kim; Seung Hyup Kim; Kyoung Sik Cho
Journal:  AJR Am J Roentgenol       Date:  2006-04       Impact factor: 3.959

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.